Thomas Wiegel

University Hospital Ulm

Papers

1

Total Citations

52

H-Index

1

About

Thomas Wiegel is a leading authority in urologic oncology, with a primary research focus on the management of clinically localized prostate cancer. His work critically evaluates the evidence base for emerging treatment modalities, particularly focal ablative therapy, against established standards of care. Wiegel’s major contribution lies in systematically dissecting the limitations of current evidence, providing a rigorous framework that guides both clinical practice and future research design. His most-cited work, a 2021 systematic review, has garnered over 50 citations, underscoring its influence in shaping treatment protocols and highlighting the need for robust comparative studies. By identifying gaps in the literature and offering clear, evidence-based recommendations, Wiegel has become a trusted voice in the ongoing debate over optimal prostate cancer management. His scholarship empowers clinicians to navigate complex treatment decisions and inspires researchers to pursue high-quality trials that can ultimately improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
52 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: University Hospital Ulm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago